256 related articles for article (PubMed ID: 23007216)
1. Melasma.
Wu IB; Lambert C; Lotti TM; Hercogová J; Sintim-Damoa A; Schwartz RA
G Ital Dermatol Venereol; 2012 Aug; 147(4):413-8. PubMed ID: 23007216
[TBL] [Abstract][Full Text] [Related]
2. Melasma: insights and perspectives.
Jadotte YT; Schwartz RA
Acta Dermatovenerol Croat; 2010; 18(2):124-9. PubMed ID: 20624364
[TBL] [Abstract][Full Text] [Related]
3. Melasma.
Lee BW; Schwartz RA; Janniger CK
G Ital Dermatol Venereol; 2017 Feb; 152(1):36-45. PubMed ID: 27589484
[TBL] [Abstract][Full Text] [Related]
4. Melasma. Etiologic and therapeutic considerations.
Grimes PE
Arch Dermatol; 1995 Dec; 131(12):1453-7. PubMed ID: 7492140
[TBL] [Abstract][Full Text] [Related]
5. Advances in the treatment of melasma: a review of the recent literature.
Ball Arefiev KL; Hantash BM
Dermatol Surg; 2012 Jul; 38(7 Pt 1):971-84. PubMed ID: 22583339
[TBL] [Abstract][Full Text] [Related]
6. Melasma: a review.
Victor FC; Gelber J; Rao B
J Cutan Med Surg; 2004; 8(2):97-102. PubMed ID: 15685388
[TBL] [Abstract][Full Text] [Related]
7. Melasma: treatment strategy.
Sehgal VN; Verma P; Srivastava G; Aggarwal AK; Verma S
J Cosmet Laser Ther; 2011 Dec; 13(6):265-79. PubMed ID: 21981383
[TBL] [Abstract][Full Text] [Related]
8. Q-switched alexandrite laser-assisted treatment of melasma: 2-year follow-up monitoring.
Rusciani A; Motta A; Rusciani L; Alfano C
J Drugs Dermatol; 2005; 4(6):770-4. PubMed ID: 16302566
[TBL] [Abstract][Full Text] [Related]
9. Hyperpigmentation and melasma.
Rigopoulos D; Gregoriou S; Katsambas A
J Cosmet Dermatol; 2007 Sep; 6(3):195-202. PubMed ID: 17760699
[TBL] [Abstract][Full Text] [Related]
10. Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study.
Attwa E; Khater M; Assaf M; Haleem MA
Int J Dermatol; 2015 Feb; 54(2):235-44. PubMed ID: 25266556
[TBL] [Abstract][Full Text] [Related]
11. Newer and upcoming therapies for melasma.
Sarkar R; Chugh S; Garg VK
Indian J Dermatol Venereol Leprol; 2012; 78(4):417-28. PubMed ID: 22772611
[TBL] [Abstract][Full Text] [Related]
12. The treatment of melasma: a review of clinical trials.
Gupta AK; Gover MD; Nouri K; Taylor S
J Am Acad Dermatol; 2006 Dec; 55(6):1048-65. PubMed ID: 17097400
[TBL] [Abstract][Full Text] [Related]
13. Melasma in men.
Vachiramon V; Suchonwanit P; Thadanipon K
J Cosmet Dermatol; 2012 Jun; 11(2):151-7. PubMed ID: 22672280
[TBL] [Abstract][Full Text] [Related]
14. Management of hyperpigmentation in darker racial ethnic groups.
Grimes PE
Semin Cutan Med Surg; 2009 Jun; 28(2):77-85. PubMed ID: 19608057
[TBL] [Abstract][Full Text] [Related]
15. Melasma--updated treatments.
Situm M; Kolić M; Bolanca Z; Ljubicić I; Misanović B
Coll Antropol; 2011 Sep; 35 Suppl 2():315-8. PubMed ID: 22220462
[TBL] [Abstract][Full Text] [Related]
16. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels.
Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA
Dermatol Surg; 2006 Dec; 32(12):1429-36. PubMed ID: 17199649
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of ultraviolet-induced melasma formation: A review.
Yang J; Zeng J; Lu J
J Dermatol; 2022 Dec; 49(12):1201-1210. PubMed ID: 35946331
[TBL] [Abstract][Full Text] [Related]
18. Future therapies in melasma: What lies ahead?
Sarkar R; Bansal A; Ailawadi P
Indian J Dermatol Venereol Leprol; 2020; 86(1):8-17. PubMed ID: 31793496
[TBL] [Abstract][Full Text] [Related]
19. Therapeutical approaches in melasma.
Prignano F; Ortonne JP; Buggiani G; Lotti T
Dermatol Clin; 2007 Jul; 25(3):337-42, viii. PubMed ID: 17662899
[TBL] [Abstract][Full Text] [Related]
20. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma.
Ortonne JP; Arellano I; Berneburg M; Cestari T; Chan H; Grimes P; Hexsel D; Im S; Lim J; Lui H; Pandya A; Picardo M; Rendon M; Taylor S; Van Der Veen JP; Westerhof W
J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1254-62. PubMed ID: 19486232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
